Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 46 publications
The win ratio for evaluating edoxaban vs dalteparin for cancer-associated venous thromboembolism: an analysis of the randomized Hokusai Venous Thromboembolism Cancer trial.
Journal: Journal of thrombosis and haemostasis : JTH
Published: July 18, 2025
Treatment and outcomes after on-treatment recurrent venous thromboembolism in patients with cancer: a post hoc analysis of the Hokusai venous thromboembolism cancer study.
Journal: Journal of thrombosis and haemostasis : JTH
Published: November 07, 2024
Advocating for neonatology presence at births between 20 and 25 weeks of gestation.
Journal: Seminars in fetal & neonatal medicine
Published: October 24, 2024
Risk of Recurrent Venous Thromboembolism in Patients with Cancer: An Individual Patient Data Meta-analysis and Development of a Prediction Model.
Journal: Thrombosis and haemostasis
Published: September 19, 2024
Impact of mild thrombocytopenia on bleeding and recurrent thrombosis in cancer.
Journal: Haematologica
Published: August 28, 2023
Inhibition of thrombin-activatable fibrinolysis inhibitor via DS-1040 to accelerate clot lysis in patients with acute pulmonary embolism: a randomized phase 1b study.
Journal: Journal of thrombosis and haemostasis : JTH
Published: October 28, 2022
Edoxaban for Thromboembolism Prevention in Pediatric Patients With Cardiac Disease.
Journal: Journal of the American College of Cardiology
Published: August 10, 2022
Ischaemic and bleeding risk in atrial fibrillation with and without peripheral artery disease and efficacy and safety of full- and half-dose edoxaban vs. warfarin: insights from ENGAGE AF-TIMI 48.
Journal: European heart journal. Cardiovascular pharmacotherapy
Published: October 13, 2021
Long-Term Risk for Major Bleeding During Extended Oral Anticoagulant Therapy for First Unprovoked Venous Thromboembolism : A Systematic Review and Meta-analysis.
Journal: Annals of internal medicine
Published: September 13, 2021
Edoxaban Exposure in Patients With Atrial Fibrillation and Estimated Creatinine Clearance Exceeding 100 mL/min.
Journal: Clinical pharmacology in drug development
Published: September 01, 2021
Postthrombotic syndrome and quality of life after deep vein thrombosis in patients treated with edoxaban versus warfarin.
Journal: Research and practice in thrombosis and haemostasis
Published: August 06, 2021
ENNOBLE-ATE trial: an open-label, randomised, multi-centre, observational study of edoxaban for children with cardiac diseases at risk of thromboembolism.
Journal: Cardiology in the young
Published: August 04, 2021
Last Updated: 09/26/2026